BBS-Bioactive Bone Substitutes Oyj (BONEH) — Strategic Asset Allocation Index
BBS-Bioactive Bone Substitutes Oyj (BONEH) has a Strategic Asset Allocation Index of 21.6% as of June 2023. Strategic assets (PP&E of €942.00K plus long-term investments of €-) total €942.00K, measured against net assets of €4.36 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. For live market cap and overall valuation, see BBS-Bioactive Bone Substitutes Oyj stock valuation.
SAAI
Strategic Assets
PP&E
Net Assets
BBS-Bioactive Bone Substitutes Oyj Strategic Asset Allocation Index (2017–2022)
This chart shows how BBS-Bioactive Bone Substitutes Oyj's Strategic Asset Allocation Index has evolved across 6 annual periods from 2017 to 2022. As of June 2023, the index stands at 21.6%, representing strategic assets of €942.00K against net assets of €4.36 Million EUR. See BBS-Bioactive Bone Substitutes Oyj (BONEH) net asset quality to measure how much of total assets are equity-financed.
Annual Strategic Asset Allocation Index for BBS-Bioactive Bone Substitutes Oyj (2017–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for BBS-Bioactive Bone Substitutes Oyj from 2017 to 2022, covering 6 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. Also explore BBS-Bioactive Bone Substitutes Oyj (BONEH) equity growth momentum to track the company's year-over-year net asset growth rate.
| Year | SAAI | Strategic Assets (EUR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 24.0% | €1.02 Million | €1.02 Million | €- | €4.27 Million | ▼ -7.6 pp |
| 2021 | 31.6% | €1.15 Million | €1.15 Million | €- | €3.63 Million | ▲ +11.8 pp |
| 2020 | 19.8% | €1.20 Million | €1.20 Million | €- | €6.09 Million | ▼ -21.9 pp |
| 2019 | 41.7% | €1.28 Million | €1.28 Million | €- | €3.08 Million | ▲ +9.7 pp |
| 2018 | 32.0% | €1.41 Million | €1.41 Million | €- | €4.42 Million | ▼ -109.9 pp |
| 2017 | 141.8% | €1.53 Million | €1.53 Million | €- | €1.08 Million | — |